Preparations for implementing human papillomavirus vaccination should begin.
Lehtinen
Matti
M
National Public Health Institute, Oulu, Finland. Matti.Lehtinen@uta.fi
D000293:Adolescent; D003140:Communicable Disease Control / Q000458:organization & administration*; D004196:Disease Outbreaks / Q000517:prevention & control / Q000706:statistics & numerical data; D005260:Female; D005833:Genital Neoplasms, Female / Q000453:epidemiology* / Q000517:prevention & control*; D014943:Global Health; D006285:Health Planning / Q000458:organization & administration; D006801:Humans; D008297:Male; D032541:Mass Vaccination / Q000458:organization & administration*; D030361:Papillomavirus Infections / Q000453:epidemiology* / Q000517:prevention & control*; D011159:Population Surveillance; D012749:Sexually Transmitted Diseases / Q000453:epidemiology / Q000517:prevention & control; D014412:Tumor Virus Infections; D014765:Viral Vaccines / Q000627:therapeutic use*; D014944:World Health Organization / Q000458:organization & administration
D014765:Viral Vaccines